Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
Clinical Trials as Topic
Communicable Diseases, Emerging
/ prevention & control
Ebola Vaccines
/ immunology
Genetic Vectors
Hemorrhagic Fever, Ebola
/ prevention & control
Humans
Vaccines, Attenuated
Vesiculovirus
Viral Proteins
/ immunology
Viral Vaccines
/ immunology
Virus Diseases
/ prevention & control
World Health Organization
Ebola virus
Lassa virus
Marburg virus
Nipah virus
V920
VSV-EBOV
emerging infections
rVSV
vector vaccine
vesicular stomatitis virus
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
2
8
2019
medline:
19
2
2020
entrez:
2
8
2019
Statut:
ppublish
Résumé
The devastating Ebola virus (EBOV) outbreak in West Africa in 2013-2016 has flagged the need for the timely development of vaccines for high-threat pathogens. To be better prepared for new epidemics, the WHO has compiled a list of priority pathogens that are likely to cause future outbreaks and for which R&D efforts are, therefore, paramount (R&D Blueprint: https://www.who.int/blueprint/priority-diseases/en/ ). To this end, the detailed characterization of vaccine platforms is needed. The vesicular stomatitis virus (VSV) has been established as a robust vaccine vector backbone for infectious diseases for well over a decade. The recent clinical trials testing the vaccine candidate VSV-EBOV against EBOV disease now have added a substantial amount of clinical data and suggest VSV to be an ideal vaccine vector candidate for outbreak pathogens. In this review, we discuss insights gained from the clinical VSV-EBOV vaccine trials as well as from animal studies investigating vaccine candidates for Blueprint pathogens.
Identifiants
pubmed: 31368826
doi: 10.1080/21645515.2019.1649532
pmc: PMC6816421
doi:
Substances chimiques
Ebola Vaccines
0
Vaccines, Attenuated
0
Viral Proteins
0
Viral Vaccines
0
Types de publication
Letter
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2269-2285Références
Biotechnol Genet Eng Rev. 2018 Apr;34(1):122-138
pubmed: 29781359
PLoS One. 2009;4(5):e5547
pubmed: 19440245
Sci Rep. 2019 May 23;9(1):7755
pubmed: 31123310
J Infect Dis. 2011 Nov;204 Suppl 3:S1082-9
pubmed: 21987745
Vaccine. 2008 Dec 9;26(52):6894-900
pubmed: 18930776
PLoS One. 2014 Apr 23;9(4):e94355
pubmed: 24759889
Vaccine. 2019 Apr 10;37(16):2174-2178
pubmed: 30878249
J Infect Dis. 2011 Nov;204 Suppl 3:S1075-81
pubmed: 21987744
Virol Sin. 2019 Feb;34(1):106-110
pubmed: 30820837
Nature. 2015 Apr 30;520(7549):688-691
pubmed: 25853476
J Virol. 2011 Dec;85(23):12781-91
pubmed: 21917979
N Engl J Med. 2017 Oct 12;377(15):1438-1447
pubmed: 29020589
JAMA. 2015 Mar 24-31;313(12):1249-55
pubmed: 25742465
Vaccine. 2009 Feb 5;27(6):893-903
pubmed: 19070640
Science. 2015 Aug 14;349(6249):739-42
pubmed: 26249231
PLoS Pathog. 2007 Jan;3(1):e2
pubmed: 17238284
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
J Gen Virol. 2018 Jul;99(7):866-879
pubmed: 29869979
J Infect Dis. 2018 Nov 22;218(suppl_5):S582-S587
pubmed: 29939296
NPJ Vaccines. 2016;1:null
pubmed: 28706736
Emerg Infect Dis. 2015 Feb;21(2):305-7
pubmed: 25625358
Vaccine. 2015 Jun 4;33(24):2823-9
pubmed: 25865472
Viruses. 2014 Jan 31;6(2):516-23
pubmed: 24492621
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
Vaccine. 2017 Aug 16;35(35 Pt A):4465-4469
pubmed: 28647166
J Virol. 2004 May;78(10):5458-65
pubmed: 15113924
Reprod Health. 2017 Dec 14;14(Suppl 3):157
pubmed: 29297408
Lancet. 2018 Mar 17;391(10125):1021
pubmed: 29565013
Nat Med. 2016 Jul 7;22(7):701-5
pubmed: 27387881
J Virol. 2011 Mar;85(5):2004-11
pubmed: 21177820
Lancet Infect Dis. 2018 Jul;18(7):738-748
pubmed: 29627147
Lancet Infect Dis. 2017 Dec;17(12):1276-1284
pubmed: 29033032
J Infect Dis. 2011 Nov;204 Suppl 3:S785-90
pubmed: 21987751
N Engl J Med. 2016 Apr 28;374(17):1647-60
pubmed: 25830326
Nat Commun. 2018 Aug 3;9(1):3067
pubmed: 30076287
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1893-8
pubmed: 23319647
J Virol. 2009 Jul;83(14):7296-304
pubmed: 19386702
J Virol. 2017 Feb 28;91(6):
pubmed: 28077641
PLoS Med. 2017 Oct 6;14(10):e1002402
pubmed: 28985239
Genome Biol. 2017 Jan 19;18(1):4
pubmed: 28100256
J Infect Dis. 2019 Jan 29;219(4):556-561
pubmed: 30452666
Sci Transl Med. 2017 Apr 12;9(385):
pubmed: 28404856
EBioMedicine. 2017 May;19:107-118
pubmed: 28434944
Virus Genes. 2017 Aug;53(4):501-515
pubmed: 28447193
PLoS One. 2018 Sep 20;13(9):e0202753
pubmed: 30235286
MMWR Suppl. 2016 Jul 08;65(3):98-106
pubmed: 27387395
Vaccine. 2014 May 7;32(22):2637-44
pubmed: 24631094
Antiviral Res. 2014 Jan;101:26-9
pubmed: 24184127
Science. 2019 Jan 4;363(6422):74-77
pubmed: 30606844
J Virol. 2001 Sep;75(18):8724-32
pubmed: 11507217
J Virol. 2008 Jun;82(11):5664-8
pubmed: 18385248
NPJ Vaccines. 2019 Feb 8;4:8
pubmed: 30774999
Sci Rep. 2016 Jun 21;6:27944
pubmed: 27323685
J Virol. 2018 Jan 17;92(3):
pubmed: 29142131
Cell Rep. 2017 Aug 29;20(9):2251-2261
pubmed: 28854372
J Infect Dis. 2016 Mar 15;213(6):930-3
pubmed: 26563239
Int J Infect Dis. 2018 Sep;74:83-96
pubmed: 29981944
PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736
pubmed: 25884628
Korean J Intern Med. 2018 Mar;33(2):233-246
pubmed: 29506344
PLoS Med. 2005 Jun;2(6):e183
pubmed: 15971954
J Virol. 1999 May;73(5):3723-32
pubmed: 10196265
Vaccine X. 2019 Jan 29;1:100009
pubmed: 31384731
Virology. 2008 Jun 20;376(1):165-72
pubmed: 18396306
Front Immunol. 2019 Jan 22;9:3071
pubmed: 30723475
Vaccine. 2018 Sep 25;:null
pubmed: 30266489
Antiviral Res. 2018 Feb;150:30-38
pubmed: 29246504
Hum Vaccin Immunother. 2017 Dec 2;13(12):2755-2762
pubmed: 28375764
CMAJ. 2017 Oct 30;189(43):E1326-E1327
pubmed: 29084758
J Infect Dis. 2017 Jun 15;215(12):1789-1798
pubmed: 28549145
Virology. 2005 Sep 30;340(2):174-82
pubmed: 16043204
MBio. 2019 May 28;10(3):
pubmed: 31138743
Vaccine. 2016 Jul 29;34(35):4196-4204
pubmed: 27373596
Arch Virol. 2010 Dec;155(12):2083-103
pubmed: 21046175
BioDrugs. 2019 Feb;33(1):9-14
pubmed: 30604389
Open Forum Infect Dis. 2015 Jun 05;2(3):ofv082
pubmed: 26199949
J Immunol. 2017 Apr 15;198(8):3023-3028
pubmed: 28289159
Lancet Infect Dis. 2017 Aug;17(8):854-866
pubmed: 28606591
Lancet. 2018 Mar 17;391(10125):1021-1022
pubmed: 29565012
Lancet. 2015 Aug 29;386(9996):857-66
pubmed: 26248676
Sci Rep. 2018 Jul 23;8(1):11043
pubmed: 30038228
J Virol. 2013 Jan;87(1):395-402
pubmed: 23077320
Lancet. 2006 Apr 29;367(9520):1399-404
pubmed: 16650649
J Virol. 2007 Feb;81(4):2056-64
pubmed: 17151112
N Engl J Med. 2018 Jun 21;378(25):2353-2355
pubmed: 29791249
Drug Des Devel Ther. 2018 Aug 14;12:2519-2527
pubmed: 30147299
CMAJ. 2017 Jun 19;189(24):E819-E827
pubmed: 28630358
Hum Vaccin Immunother. 2016 Sep;12(9):2327-33
pubmed: 27185081
J Virol. 2006 Oct;80(19):9659-66
pubmed: 16973570
Clin Infect Dis. 2016 Aug 1;63(3):376-9
pubmed: 27118786
NPJ Vaccines. 2019 Jan 25;4:5
pubmed: 30701094
Nat Microbiol. 2018 Oct;3(10):1084-1089
pubmed: 30150734
J Infect Dis. 2016 Oct 15;214(suppl 3):S360-S366
pubmed: 27496978
Lancet Infect Dis. 2015 Oct;15(10):1156-1166
pubmed: 26248510
J Infect Dis. 2007 Nov 15;196 Suppl 2:S404-12
pubmed: 17940977
Nat Rev Drug Discov. 2018 Jun;17(6):413-434
pubmed: 29375139
Emerg Infect Dis. 2019 Aug;25(8):1563-1566
pubmed: 31141474
PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2600
pubmed: 24367715
J Virol. 2000 Dec;74(23):10903-10
pubmed: 11069984
Vaccine. 2016 Dec 12;34(51):6597-6609
pubmed: 27395563
J Gen Virol. 2016 Feb;97(2):269-73
pubmed: 26684466
J Infect Dis. 2018 May 18;217(suppl_1):S6-S15
pubmed: 29788345
J Infect Dis. 2015 Oct 1;212 Suppl 2:S443-51
pubmed: 26109675
Vaccine. 2018 Jun 22;36(27):3894-3900
pubmed: 29807712
Lancet Infect Dis. 2018 Jun;18(6):e183-e192
pubmed: 29153266
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4477-81
pubmed: 7753828
Cell. 2001 Sep 7;106(5):539-49
pubmed: 11551502
PLoS Pathog. 2008 Nov;4(11):e1000225
pubmed: 19043556
Emerg Infect Dis. 2010 Jul;16(7):1119-22
pubmed: 20587184
Nature. 2016 May 5;533(7601):100-4
pubmed: 27147028
PLoS One. 2010 May 18;5(5):e10690
pubmed: 20502528
Nat Med. 2005 Jul;11(7):786-90
pubmed: 15937495
N Engl J Med. 2017 Jan 26;376(4):330-341
pubmed: 25830322
J Infect Dis. 2011 Nov;204 Suppl 3:S1090-7
pubmed: 21987746